Articles

Numinus Becomes The First Canadian Psychedelics Company To Legally Harvest Magic Mushrooms

Numinus Becomes The First Canadian Psychedelics Company To Legally Harvest Magic Mushrooms

Numinus CEO Payton Nyquvest and COO Michael Tan sat down with Forbes to discuss the company's harvest of psilocybe mushrooms, the first legal harvest in Canada since the 1970s. Click here to read…

Vancouver company completes first legal harvest of psilocybe mushrooms

Vancouver company completes first legal harvest of psilocybe mushrooms

Vancouver-based Numinus Wellness Inc. has completed its first harvest of psilocybe mushrooms, said to be the most common psilocybin-containing mushroom. Click here to read more.

How Numinus is positioning itself to be a trusted leader for the eventual rollout of psychedelic-assisted psychotherapies in the healthcare system

How Numinus is positioning itself to be a trusted leader for the eventual rollout of psychedelic-assisted psychotherapies in the healthcare system

Learn more about Numinus' plans to work directly with international partners and regulators to develop and set post-research market standards for psychedelic-assisted psychotherapy. Click here to…

How Numinus plans to support psychedelic assisted psychotherapy access to Canadians and beyond

How Numinus plans to support psychedelic assisted psychotherapy access to Canadians and beyond

Find out about the traction that psychedelic-assisted psychotherapy is gaining in the medical community and how Numinus plans to become a future potential supplier, scientific leader and clinical…

B.C. researchers, advocates, and companies at forefront of Canada's psychedelic revolution

B.C. researchers, advocates, and companies at forefront of Canada's psychedelic revolution

The Georgia Straight's Charlie Smith explores the history of psychedelic-assisted psychotherapy in British Columbia and the role that Vancouver companies like Numinus are playing in its revival.…

Is psilocybin the next cannabis? New research is chipping away at the stigma attached to psychedelics

Is psilocybin the next cannabis? New research is chipping away at the stigma attached to psychedelics

The Toronto Star explores the difference between microdosing and psychedelic-assisted psychotherapy, the research driving renewed interest in the field, and how regulation of these substances could…

MAPS Canada advances understanding about psychedelic medicines

MAPS Canada advances understanding about psychedelic medicines

For the past decade, executive director Mark Haden has been educating physicians on how psychedelic substances could help patients with posttraumatic stress disorder, treatment-resistant depression,…

Company with Nanaimo lab gets federal approval for psychedelic drug research

Company with Nanaimo lab gets federal approval for psychedelic drug research

Numinus's recently amended Health Canada licence allows the company to produce and extract psilocybin from mushrooms. The Nanaimo News Bulletin speaks with Numinus CEO Payton Nyquvest about the…

Conversations That Matter: Payton Nyquvest and Dr. Evan Wood

Conversations That Matter: Payton Nyquvest and Dr. Evan Wood

In a special to the Vancouver Sun, Simon Fraser University's Stu McNish speaks with Numinus CEO Payton Nyquvest and Chief Medical Officer Dr. Evan Wood. Click here to read more.

Healthcare company Numinus looks to address mental health and addiction with psychedelic assisted therapy

Healthcare company Numinus looks to address mental health and addiction with psychedelic assisted therapy

Numinus leaders explore how research, development, testing, and treatment centres will be key to advancing and implementing psychedelic-assisted therapies. Click here to read more.

Healthcare company Numinus believes psychedelic assisted therapy can improve mental health outcomes

Healthcare company Numinus believes psychedelic assisted therapy can improve mental health outcomes

Numinus CEO Payton Nyquvest and Chief Medical Officer Dr. Evan Wood discuss the potential of psychedelic-assisted psychotherapy to transform existing treatment models of mental health and addition -…

The business of producing psychedelics for science

The business of producing psychedelics for science

The Daily Hive's Peter Smith speaks to Numinus CEO Payton Nyquvest about the business side of psychedelic-assisted therapy research and how Numinus's amended Health Canada licence puts them in a…